Abstract
Contact and support
Need help, have a question, or want to contact the ResearchHub team?
© 2026 ResearchHub. Built for responsible scholarly connection.
Matic Pavlin, Barbara Herlah, Katja Valjavec, Andrej Perdih
Abstract
Authors
Institutions
No ROR-resolved institution is linked to this work yet.
Provenance
crossref
Confidence 100%
pubmed
Confidence 98%
europepmc
Confidence 96%
unpaywall
Confidence 95%
doaj
Confidence 92%
datacite
Confidence 0%
No local reference links have been materialized yet.
No local citing links have been materialized yet.
10.1038/nrc2608
10.1038/nrc2608
10.1038/nrm3228
10.1038/nrm3228
10.1017/s0033583598003424
10.1017/s0033583598003424
10.1038/nrm831
10.1038/nrm831
10.1146/annurev.biochem.70.1.369
10.1146/annurev.biochem.70.1.369
10.1017/s003358350800468x
10.1017/s003358350800468x
10.1038/nrm.2016.111
10.1038/nrm.2016.111
10.1016/s0167-4781(98)00128-6
10.1016/s0167-4781(98)00128-6
10.1016/j.mrfmmm.2007.06.009
10.1016/j.mrfmmm.2007.06.009
10.1038/nrc2607
10.1038/nrc2607
Type II DNA topoisomerase from Saccharomyces cerevisiae is a stable dimer
10.1021/bi970152f · 1997
10.1002/bies.202000286
10.1002/bies.202000286
10.1038/nsmb.2388
10.1038/nsmb.2388
The N-terminal domain of human topoisomerase IIalpha is a DNA-dependent ATPase
10.1021/bi9818321 · 1998
10.1073/pnas.96.24.13685
10.1073/pnas.96.24.13685
10.1016/s0968-0004(99)01503-0
10.1016/s0968-0004(99)01503-0
10.1074/jbc.275.17.13041
10.1074/jbc.275.17.13041
The QTK loop is essential for the communication between the N-terminal ATPase domain and the central cleavage-ligation region in human topoisomerase II alpha
10.1021/bi9005978 · 2009
10.1016/j.sbi.2012.11.011
10.1016/j.sbi.2012.11.011
10.1073/pnas.1115704109
10.1073/pnas.1115704109
10.1038/nature08974
10.1038/nature08974
The interplay between DNA topoisomerase 2alpha post-translational modifications and drug resistance
2020
Post-translational modifications in DNA topoisomerase 2alpha highlight the role of a eukaryote-specific residue in the ATPase domain
10.1038/s41598-018-27606-8 · 2018
DNA transport by a type II DNA topoisomerase: evidence in favor of a two-gate mechanism
10.1016/0092-8674(94)90222-4 · 1994
DNA transport by a type II topoisomerase: direct evidence for a two-gate mechanism
10.1073/pnas.93.9.4057 · 1996
10.1074/jbc.m402555200
10.1074/jbc.m402555200
10.1039/c003759a
10.1039/c003759a
Probing conformational changes in human DNA topoisomerase IIalpha by pulsed alkylation mass spectrometry
10.1074/jbc.m112.377606 · 2012
10.1093/nar/gkr258
10.1093/nar/gkr258
10.1042/bst0380438
10.1042/bst0380438
Energy coupling in type II topoisomerases: why do they hydrolyze ATP?
10.1021/bi700789g · 2007
A human topoisomerase II alpha heterodimer with only one ATP binding site can go through successive catalytic cycles
10.1074/jbc.m210332200 · 2003
Bioassays and in silico methods in the identification of human DNA topoisomerase IIα inhibitors
10.2174/0929867325666180306165725 · 2018
10.1002/cpz1.250
10.1002/cpz1.250
10.1038/nature06396
10.1038/nature06396
10.1038/s41467-018-05406-y
10.1038/s41467-018-05406-y
Structure and mechanism of DNA topoisomerase II
10.1038/379225a0 · 1996
10.1074/jbc.m506520200
10.1074/jbc.m506520200
10.1016/j.str.2022.05.009
10.1016/j.str.2022.05.009
10.1038/s41467-021-23136-6
10.1038/s41467-021-23136-6
10.1021/ci049885e
10.1021/ci049885e · doi-reference
Recent developments and applications of the MMPBSA method
10.3389/fmolb.2017.00087 · doi-reference
The MM/PBSA and MM/GBSA methods to estimate ligand-binding affinities
10.1517/17460441.2015.1032936 · doi-reference
10.1021/ct700119m
10.1021/ct700119m · doi-reference
10.1002/prot.20784
10.1002/prot.20784 · doi-reference
10.1093/bioinformatics/btr168
10.1093/bioinformatics/btr168 · doi-reference
visualization system for exploratory research and analysis
10.1002/jcc.20084 · doi-reference
10.1016/0263-7855(96)00018-5
10.1016/0263-7855(96)00018-5 · doi-reference
10.1093/nar/gkr316
10.1093/nar/gkr316 · doi-reference
10.1093/bioinformatics/btl461
10.1093/bioinformatics/btl461 · doi-reference
10.1016/0021-9991(77)90098-5
10.1016/0021-9991(77)90098-5 · doi-reference
Molecular-dynamics study of atomic motions in water
10.1103/physrevb.31.2643 · doi-reference
10.1063/1.464397
10.1063/1.464397 · doi-reference
10.1063/1.448118
10.1063/1.448118 · doi-reference
10.1103/physreva.33.3628
10.1103/physreva.33.3628 · doi-reference
Application of the multimolecule and multiconformational RESP methodology to biopolymers: Charge derivation for DNA, RNA, and proteins
10.1002/jcc.540161106 · doi-reference
Application of RESP charges to calculate conformational energies, hydrogen bond energies, and free energies of solvation
10.1021/ja00074a030 · doi-reference
10.1021/j100384a009
10.1021/j100384a009 · doi-reference
10.1002/jcc.10262
10.1002/jcc.10262 · doi-reference
10.1038/nmeth.3658
10.1038/nmeth.3658 · doi-reference
10.1021/acs.jctc.5b00255
10.1021/acs.jctc.5b00255 · doi-reference
10.1063/1.445869
10.1063/1.445869 · doi-reference
10.1002/prot.20922
10.1002/prot.20922 · doi-reference
10.1093/nar/gki464
10.1093/nar/gki464 · doi-reference
10.1093/nar/gks375
10.1093/nar/gks375 · doi-reference
10.1110/ps.062416606
10.1110/ps.062416606 · doi-reference
Modeller: generation and refinement of homology-based protein structure models
10.1016/s0076-6879(03)74020-8 · doi-reference
10.1006/jmbi.1993.1626
10.1006/jmbi.1993.1626 · doi-reference
10.1093/nar/gkv672
10.1093/nar/gkv672 · doi-reference
10.1093/nar/gkt749
10.1093/nar/gkt749 · doi-reference
Structural basis of gate-DNA breakage and resealing by type II topoisomerases
10.1371/annotation/deacc2fd-665b-4736-b668-dc69a38bb4f9 · doi-reference
The nucleic acid database. A comprehensive relational database of three-dimensional structures of nucleic acids
10.1016/s0006-3495(92)81649-1 · doi-reference
A standard reference frame for the description of nucleic acid base-pair geometry
10.1006/jmbi.2001.4987 · doi-reference
DNA G-segment bending is not the sole determinant of topology simplification by type II DNA topoisomerases
10.1038/srep06158 · doi-reference
Large-scale conformational changes and protein function: breaking the in silico barrier
10.3389/fmolb.2019.00117 · doi-reference
Next generation 3D pharmacophore modeling
10.1002/wcms.1468 · doi-reference
10.1093/nar/gkn937
10.1093/nar/gkn937 · doi-reference
10.1093/nar/gkn994
10.1093/nar/gkn994 · doi-reference
Essential dynamics: foundation and applications
10.1002/wcms.1099 · doi-reference
Collective motions in proteins: a covariance analysis of atomic fluctuations in molecular dynamics and normal mode simulations
10.1002/prot.340110305 · doi-reference